HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

This study is testing a drug called defactinib for people with advanced cancers that have a specific genetic change called an NF2 mutation. The drug aims to block a protein that these cancer cells may need to grow. Researchers want to see if taking defactinib pills twice a day ca…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 20:55 UTC

Targeted pill trial aims to stop growth of Hard-to-Treat cancers

This study is testing whether a pill called palbociclib can shrink or stop the growth of advanced cancers that have specific genetic changes (CCND1, 2, or 3 amplification). The drug works by blocking proteins that help cancer cells grow. The trial is for adults with advanced soli…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

Targeted attack on Cancer's genetic weak spot

This study is testing whether the drug crizotinib can help people with advanced cancers that have a specific genetic change called a ROS1 translocation. The drug aims to block a protein that these cancer cells need to grow. Researchers want to see if taking crizotinib daily can s…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

New hope for tough cancers: experimental drug targets specific genetic flaw

This study is testing whether a drug called ado-trastuzumab emtansine can shrink or stop the growth of advanced cancers that have a specific genetic change called HER2 amplification. The trial is for patients with various hard-to-treat cancers (like lymphoma and solid tumors), bu…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

Can a home workout and a supplement help cancer survivors fight prediabetes?

This small pilot study is testing whether a home exercise program, with or without a vitamin B3-like supplement called nicotinamide riboside, is practical and helpful for adult survivors of childhood cancer who have prediabetes. The main goal is to see if survivors can stick to t…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Apr 02, 2026 14:58 UTC

New drug targets specific cancer mutation in patients out of options

This study is testing an experimental drug called AZD5363 in patients with advanced cancers that have a specific genetic change called an AKT mutation. The drug is designed to block the AKT protein, which cancer cells need to grow. Researchers want to see if taking this pill can …

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 02, 2026 14:58 UTC

Scientists test new drug to boost Cancer-Fighting immune cells

Disease control Terminated

This early-stage study is testing the safety of a drug called atezolizumab in cancer patients who have already received a special immune cell therapy. The goal is to see if this drug can help the transferred immune cells work better against the cancer. The study will enroll about…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC

Early trial aims to train immune system to fight childhood cancers

This early-phase study aimed to test the safety and find the right dose of a two-drug immunotherapy (nivolumab and ipilimumab) for children, teens, and young adults whose cancers had returned or stopped responding to standard treatments. The drugs work by helping the patient's ow…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 02, 2026 14:56 UTC

Targeted attack on Cancer's genetic weakness

This study is testing whether the drug taselisib can shrink or stop the growth of advanced cancers that have a specific genetic change called a PIK3CA mutation. It is for patients whose cancer has not responded to standard treatments. The goal is to see if blocking the faulty PIK…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 02, 2026 14:56 UTC

New drug trial offers hope for stem cell transplant complications

This study is testing whether the drug acalabrutinib can help control chronic graft-versus-host disease in adults who have had a stem cell transplant. The trial involves 51 participants whose condition worsened despite steroid treatment. Patients take the medication orally for up…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

Targeted pill aims to block Cancer's growth signal in Tough-to-Treat tumors

This study is testing an experimental pill called GSK2636771 for people with advanced cancers that have stopped responding to other treatments and have a specific genetic change called a PTEN mutation. The pill is designed to block a protein that these cancer cells may need to gr…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

Targeted pill tested for Hard-to-Treat cancers with rare genetic flaws

This study is testing a pill called trametinib for people with advanced cancers that have stopped responding to other treatments and have specific changes in a gene called BRAF. The pill aims to block proteins that these cancer cells need to grow. Researchers want to see if the t…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

Can virtual coaching help cancer survivors live healthier lives?

This study is testing different ways to help childhood and young adult cancer survivors become more physically active and improve their diets. Researchers are comparing several approaches including telehealth sessions with clinicians, personalized goal-setting with social media s…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

Targeted drug tested for tough cancers with specific genetic flaw

This study is testing a drug called trametinib for people with advanced cancers that have a specific genetic change called an NF1 mutation. The drug works by blocking proteins that these cancer cells may need to grow. Researchers want to see if trametinib can shrink these tumors …

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

Scientists test pill to supercharge radiation against brain cancer

This early-stage study is testing a new oral drug called IPdR (ropidoxuridine) in combination with standard whole-brain radiation therapy. The goal is to see if the drug makes cancer cells in the brain more sensitive to radiation, potentially improving treatment for patients whos…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

Targeted drug tested for Hard-to-Treat cancers with specific genetic flaw

This study is testing if the drug trametinib can help control advanced cancers that have specific genetic changes called GNAQ or GNA11 mutations. It is for patients with various cancers, including solid tumors and lymphomas, that have not responded to other treatments. The goal i…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

New antibody drug enters human testing for Tough-to-Treat blood cancers

This is a first-in-human study to find a safe dose of an experimental antibody drug called Hu8F4 for patients with advanced blood cancers like leukemia and myelodysplastic syndrome (MDS). The main goals are to check for side effects and see how the body processes the drug. The st…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

Fighting a stubborn virus: borrowed immune cells target CMV

This study is testing a treatment for a viral infection called CMV that can be dangerous for people who have had a stem cell transplant. It uses special white blood cells from a donor who has fought off CMV before. The goal is to see if these 'borrowed' immune cells can help clea…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

New drug tested to protect kidneys during cancer treatment

This study is testing if a drug called pegloticase can quickly lower dangerously high uric acid levels in cancer patients. High uric acid is a side effect of some cancer treatments and can damage the kidneys. The goal is to see if one or two doses of pegloticase can protect kidne…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

Targeted drug trial offers new hope for Tough-to-Treat cancers

This study is testing whether a drug called afatinib can help people with advanced cancers that have a specific genetic change called a HER2 mutation. The drug works by blocking a protein that helps cancer cells grow. Researchers are enrolling about 40 patients whose cancers have…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

New transplant strategy aims to tame blood cancers and reduce rejection

This study is testing a modified stem cell transplant procedure for patients with high-risk blood cancers. The goal is to see if using specific chemotherapy drugs in a timed sequence before and after the transplant can better control the cancer while reducing harmful immune react…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

Drug duo aims to block Cancer's growth signal in Hard-to-Treat tumors

This study is testing whether two drugs, dabrafenib and trametinib, can shrink or stop the growth of advanced cancers that have a specific genetic change called a BRAF V600 mutation. It is for patients with solid tumors, lymphoma, or multiple myeloma that have not responded to ot…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

Cancer trial matches drugs to your Tumor's DNA

This large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

Targeted drug trial aims to slow advanced cancers by blocking key mutation

This trial is testing whether the drug osimertinib can help control advanced cancers that have specific changes (mutations) in a gene called EGFR. The drug works by blocking the faulty protein these mutations create, which may slow or stop cancer growth. The study is for adults w…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

New Team-Based care aims to help seniors bounce back after cancer transplant

This study is testing whether a team of different healthcare specialists can help older adults with blood cancer prepare for and recover from a stem cell transplant. The team includes doctors, therapists, a dietitian, and a social worker who work with patients for three months be…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

Targeted drug trial aims to block Cancer's growth signal

This study is testing if the drug crizotinib can shrink or stop the growth of advanced cancers that have a specific genetic change called an ALK rearrangement. It is for people with various solid tumors or blood cancers (excluding certain lung cancers and lymphomas) that have not…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

New method aims to protect babies from harsh chemo side effects

This study is testing a new way to calculate the dose of the cancer drug vincristine for infants and very young children. The goal is to give them drug levels in their blood that are similar to older children, who use a standard dosing method, while trying to reduce severe side e…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Mar 10, 2026 12:53 UTC

New drug targets a key Cancer-Causing mutation

This study is testing a drug called binimetinib in patients with advanced cancers that have a specific genetic change called an NRAS mutation. The drug works by blocking proteins that cancer cells with this mutation need to grow. Researchers want to see if the drug can shrink the…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC

New drug targets weakness in BRCA cancer cells

This study is testing whether the drug AZD1775 can shrink or stop the growth of advanced cancers that have specific genetic changes called BRCA1 or BRCA2 mutations. The drug works by blocking a protein called WEE1 that these cancer cells may need to survive. The trial will involv…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 09, 2026 14:23 UTC

Targeted pill tested to control tough cancers with missing protein

This study is testing an experimental pill called GSK2636771 for people with advanced cancers that have stopped responding to other treatments. The drug is specifically for cancers that have completely lost a protein called PTEN. Researchers want to see if the pill can shrink the…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 04, 2026 15:30 UTC

Home heart check: new portable device could catch problems early in cancer survivors

Diagnosis Ongoing

This study is testing whether portable heart monitoring devices can detect early heart problems in childhood cancer survivors as accurately as standard clinic tests. Researchers are comparing two portable devices that can be used at home against traditional echocardiograms and MR…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis

Last updated Apr 03, 2026 14:43 UTC

Donor vaccine shields cancer patients from dangerous Post-Transplant virus

Prevention Ongoing

This study is testing a new vaccine approach to prevent a common and dangerous viral infection called CMV in patients receiving a stem cell transplant for blood cancer. Researchers are vaccinating the healthy stem cell donors before the transplant, hoping the donor's boosted immu…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention

Last updated Apr 03, 2026 14:41 UTC

New vaccine aims to shield vulnerable cancer patients from dangerous virus

Prevention Ongoing

This study is testing a vaccine designed to prevent cytomegalovirus (CMV) infection in adults with blood cancers who are receiving a half-matched stem cell transplant. CMV is a common virus that can become life-threatening when the immune system is weakened after transplant. The …

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Prevention

Last updated Mar 16, 2026 15:25 UTC

Cancer breathlessness breakthrough? opioid trial aims to ease suffering

This study is testing whether fast-acting opioid pain medications (fentanyl or morphine) can help control the distressing shortness of breath that cancer patients often feel during physical activity. About 150 patients will take either one of the opioids or a placebo pill daily f…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief

Last updated Apr 03, 2026 14:42 UTC

Cancer's hidden cost: new program aims to ease financial pain for patients

This study tests whether a financial counseling program can reduce money problems and stress for people with cancer and their partners. It compares two groups: one gets basic financial education, and the other gets that plus monthly meetings with a financial counselor. The goal i…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Symptom relief

Last updated Apr 02, 2026 14:56 UTC

New combo therapy aims to ease sleepless nights for cancer patients

This study is testing a combination of treatments to help cancer patients who are having trouble sleeping. It combines counseling sessions with possible use of a stimulant, melatonin, and light therapy. The goal is to see if this package improves sleep quality, reduces fatigue, a…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief

Last updated Apr 01, 2026 14:42 UTC

Can a natural supplement soothe Chemo's painful side effects?

This study is testing if a dietary supplement called PEA can relieve nerve pain, numbness, and tingling caused by chemotherapy in cancer survivors. About 88 participants who have had these symptoms for at least 3 months will take either PEA or a placebo pill for 8 weeks. Research…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief

Last updated Mar 31, 2026 12:12 UTC

App aims to lift spirits for cancer patients battling depression

This study is testing whether adding a special digital app and web platform can improve depression care for people undergoing cancer treatment. It compares this tech-enhanced approach to the usual collaborative care methods. The goal is to see if the technology helps patients and…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: University of Washington • Aim: Symptom relief

Last updated Mar 30, 2026 14:29 UTC

Doctors test if slower pain shots reduce addiction risk in cancer patients

This study aims to find the best way to give intravenous pain medicine to hospitalized cancer patients. Researchers are comparing whether giving the drug hydromorphone quickly over 2 minutes or slowly over 15 minutes provides better pain relief while lowering the risk of patients…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief

Last updated Mar 23, 2026 15:29 UTC

Can a fitbit and social media help young cancer survivors get healthier?

This study is testing a mobile health program designed to help young people who have survived childhood cancer become more physically active. It compares a full program—which includes a Fitbit, personalized goal setting, and a social media support group—against just wearing a Fit…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Symptom relief

Last updated Mar 23, 2026 15:18 UTC

Phone app aims to guide cancer patients through radiation treatment

This study is testing a new mobile phone app designed to help cancer patients during radiation therapy. The app provides education and guidance on managing treatment side effects and logistics. Researchers want to see if patients find the app easy to use and helpful. The study in…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief

Last updated Mar 23, 2026 15:17 UTC

Can walking and light weights beat drugs for chemo pain?

This study is testing if a simple, home-based exercise program can better relieve the nerve pain, numbness, and tingling that often follows chemotherapy. About 133 cancer patients who have this side effect are being assigned to either follow a 6-week walking and resistance progra…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief

Last updated Mar 18, 2026 14:42 UTC

Scientists test new 'Glow-in-the-Dark' tracer to spot hidden cancers

This early-phase study is testing a new imaging agent called 68Ga-FAPI-46 to see where it goes in the body of patients with various cancers. Researchers will give participants the tracer and then perform PET/CT scans to see how it collects in both normal and cancerous tissues. Th…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused

Last updated Apr 03, 2026 20:55 UTC

Cancer's hidden cost: study probes financial strain on patients

This study aims to understand the financial stress cancer patients experience and what personal and social factors help them cope. Researchers will survey 625 recently diagnosed patients about their confidence, support networks, and financial knowledge. The goal is to gather info…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Apr 03, 2026 14:44 UTC

Simple 15-Minute check could predict survival for older cancer patients

This study aims to find the best way to identify malnutrition in older adults with cancer. Researchers are comparing four different short screening tools to see which one best predicts a patient's risk of dying or being hospitalized over the next year. The goal is to help doctors…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Apr 03, 2026 14:43 UTC

Cancer patients and doctors weigh in: is telemedicine working for radiation care?

This study aims to understand what cancer patients and their radiation doctors think about using video visits (telemedicine) for appointments. Researchers are surveying 200 adults who have had a video visit with their radiation oncology team, as well as the doctors themselves. Th…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Apr 03, 2026 14:42 UTC

Can virtual coffee breaks cure doctor burnout?

This study is testing if regular online team meetings can help cancer imaging doctors feel less burned out and more connected to their colleagues. Researchers are enrolling 36 doctors to either join weekly virtual meetings for 13 weeks or wait and join later. The main goal is to …

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Apr 02, 2026 14:57 UTC

Could low testosterone lead to dementia? new genetic study investigates

This study uses existing genetic and health data to investigate whether having naturally lower testosterone levels might cause an increased risk of dementia, depression, or anxiety. Researchers are analyzing information from large public health databases, not testing a new treatm…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Apr 02, 2026 14:57 UTC

Tracking the hidden toll: how transplants affect Survivors' hearts

This study aims to understand why cancer survivors who receive stem cell transplants have a higher risk of heart disease. Researchers will measure how well the heart, lungs, and muscles work together in 350 adult patients before their transplant and for two years after. The goal …

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: City of Hope Medical Center • Aim: Knowledge-focused

Last updated Apr 02, 2026 14:57 UTC

Mayo clinic aims to break down barriers to cancer trials for minority patients

This study aims to understand why minority cancer patients often don't join clinical trials and to create a personalized educational platform to help them participate. Researchers will survey nearly 600 cancer patients about their knowledge and attitudes toward trials, then test …

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused

Last updated Apr 02, 2026 14:56 UTC

Major study investigates why cancer treatments work differently across racial groups

This study aims to understand if Black and White cancer patients experience different side effects and treatment results when receiving immunotherapy drugs. Researchers will follow 2,100 patients already scheduled to receive these treatments in community cancer clinics. By collec…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: University of Rochester NCORP Research Base • Aim: Knowledge-focused

Last updated Apr 01, 2026 14:42 UTC

Researchers ask teens: how do we measure your cancer pain?

This study is testing a symptom questionnaire designed specifically for teenagers with cancer. Researchers are interviewing 13-17 year old cancer patients to see if the questionnaire accurately captures their experiences with pain, fatigue, and other symptoms. The goal is to crea…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Mar 31, 2026 12:12 UTC

Parents' fear of opioids for kids in pain: cancer center investigates

Knowledge-focused Terminated

This study aims to understand the worries parents have about giving opioid pain medication to their children with cancer. Researchers are surveying 110 parents to learn why some might hesitate to use these strong pain relievers, even when their child is hurting. The information w…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Mar 31, 2026 12:11 UTC

Can they hear us? brain wave study seeks answers for families of dying patients

This study uses brain wave monitoring to understand if cancer patients who appear completely unresponsive near the end of life can still hear or understand words. Researchers will measure brain activity in response to speech and other stimuli in 30 patients. The goal is to provid…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:33 UTC

Massive study asks: how did COVID-19 impact cancer Patients' lives?

This study aims to understand how the COVID-19 pandemic affected the well-being and quality of life of cancer patients and survivors. Researchers are surveying over 13,000 patients about their pandemic experiences, including health impacts, financial stress, and emotional challen…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:29 UTC

Cancer patients weigh in: does adding marijuana to pain meds help?

This study aims to understand cancer patients' preferences and experiences when using marijuana products (THC or CBD) alongside prescription opioids for pain. Researchers are surveying 200 patients with cancer-related pain in Texas and Arizona to learn which combination they find…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:29 UTC

Does a mask hide a Doctor's care? study tests patient feelings on video vs. In-Person visits

This study aims to understand how patients with cancer or COVID-19 perceive their doctor's empathy. Researchers are comparing two visit types: in-person where the doctor wears full protective equipment (PPE) versus a video call where the doctor does not. The goal is to learn whic…

Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM

Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:28 UTC

Researchers ask: did pandemic worsen pain for cancer survivors?